Growing lungs by combining a donor lung seeded with a patient's own lung cells could decrease the chance of rejection, and potentially improve the success of lung transplants.
如果能把病人自己的肺部细胞植入到一个供体肺中，使其成长为一个新的肺，就可以达到降低排斥反应的目的，而且很可能提高肺部移植的成功率。
The patient experience two clinical rejection instances, at days 28 and 64, with the latter attack associated with a cytomegalovirus infection that was linked to the donor tissue.
患者在术后第28天和第64天分别出现一次临床排斥事件，后一次的发生由与供者相关的巨细胞病毒感染引起。
CONCLUSION: Donor specific bone marrow infusion enhances chimerism formation in bone marrow, alleviates the rejection of liver allotransplantation and improve survival of liver allotransplantation.
结论：供体骨髓输注可形成供受体细胞的嵌合状态，可降低同种异体肝移植的排斥反应，延长受体生存时间。
Objective To study donor bone marrow infusion relieving acute rejection of rat lung allograft.
目的研究供体骨髓细胞输注减轻大鼠肺移植急性排斥反应。
The development of acute rejection and the use of deceased (vs. living) donor kidneys were also significant factors influencing graft survival.
急性排斥反应的发生和尸体肾(相对于活体供肾)运用的减少也是影响移植术后存活的显著因素。
Conclusion:HLA typing and HLA crossreactive antigen group(CREGs) matching play an important role in selecting suitable donor, reducing early rejection, improving the effect of kidney transplantation.
结论：HLA配型、交叉组配型可显著提高供受者的HLA相配率，对选择最佳的供者，降低早期急性排斥反应的发生，提高肾移植效果具有重要的意义。
Conclusions Injection of two or more kinds of donor live cells may alleviate chronic rejection via decreasing of expressions of VEGF and ET-1 in the grafts.
结论经门静脉注射两种或两种以上供体活细胞可减轻慢性排斥反应，VEGF、ET-1的表达与血管硬化及纤维化程度呈正相关。
By using the patient's own cells, there is no danger of rejection as there would be with cells from an unrelated donor.
由于是患者自身的细胞，所以也就不存在由其他不相关来源细胞所致的排斥问题。
Results After transplantation, acute rejection occurred in 71 cases, of whom 16(22.5%) had adverse changes in donor grafts;
结果移植后发生急性排斥反应71例，其中16例（2 2 .5 % ）供肾组织有不良改变；
Objective To study the relationship between HLA typing and early rejection after cadaver donor kidney transplantation.
目的研究HLA配型与尸体肾移植术后早期急性排斥反应的关系。
Heart transplantation can treat heart failure, however, it is restricted by donor sourse and immune rejection.
心脏移植可以治疗严重心功能衰竭，但这一有效治疗措施受供体来源和免疫排斥反应等的限制。
Patients did not experience any rejection reaction or require long-term immune suppression, which are serious side effects associated with the use of human donor tissue.
患者并未经历过免疫排斥反应或需要长期的免疫抑制。而免疫排斥与免疫抑制正是应用捐赠的人类角膜必然伴随的严重副作用。
Patients did not experience any rejection reaction or require long-term immune suppression, which are serious side effects associated with the use of human donor tissue.
患者并未经历过免疫排斥反应或需要长期的免疫抑制。而免疫排斥与免疫抑制正是应用捐赠的人类角膜必然伴随的严重副作用。
应用推荐